연구성과로 돌아가기

2021 연구성과별 연구자 정보 (364 / 2991)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone Park, Yong Park, Y 11 Korea Univ, Dept Internal Med, Coll Med, Seoul, South Korea ckmin@catholic.ac.kr;
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone Jo, Jae-Cheol Jo, JC 12 Univ Ulsan, Coll Med, Dept Hematol & Oncol, Ulsan Univ Hosp, Ulsan, South Korea CAE-9453-2022 Jo, Jae-Cheol ckmin@catholic.ac.kr;
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone Lee, Won Sik Lee, WS 13 Busan Paik Hosp, Dept Internal Med, Busan, South Korea ckmin@catholic.ac.kr;
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone Do, Young Rok Do, YR 14 Keimyung Univ, Dept Hematooncol, Dongsan Med Ctr, Daegu, South Korea ckmin@catholic.ac.kr;
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone Mun, Yeung-Chul Mun, YC 15 Ewha Womans Univ, Dept Internal Med, Sch Med, Seoul, South Korea ckmin@catholic.ac.kr;
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone Lee, Mark Hong Lee, MH 16 Konkuk Univ, Sch Med, Med Ctr, Div Hematol Oncol,Dept Internal Med, Seoul, South Korea ckmin@catholic.ac.kr;
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone Kim, Hyo Jung Kim, HJ 17 Hallym Univ, Coll Med, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea AAQ-3152-2020 Kim, Hyo ckmin@catholic.ac.kr;
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone Kim, Sung-Hyun Kim, SH 18 Dong A Univ, Dept Internal Med, Dong A Med Ctr, Coll Med, Busan, South Korea ckmin@catholic.ac.kr;
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone Kim, Min Kyoung Kim, MK 19 Yeungnam Univ, Dept Med, Coll Med, Daegu, South Korea ACN-6827-2022 Kim, Min ckmin@catholic.ac.kr;
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone Lim, Sung-Nam Lim, SN 20 Haeundae Baek Hosp, Dept Internal Med, Busan, South Korea ckmin@catholic.ac.kr;
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone Park, Seong Kyu Park, SK 21 Soonchunhyang Univ, Bucheon Hosp, Dept Hematol Oncol, Bucheon, South Korea ckmin@catholic.ac.kr;
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone Yi, Jun Ho Yi, JH 22 Chung Ang Univ, Div Hematol Oncol, Dept Med, Seoul, South Korea GXZ-8144-2022 Yi, Jun Ho ckmin@catholic.ac.kr;
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone Lee, Jae Hoon Lee, JH 23 Gachon Univ, Dept Internal Med, Gil Hosp, Incheon, South Korea ckmin@catholic.ac.kr;
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone Min, Chang-Ki Min, CK 24 교신저자 Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, 505 Banpo Dong, Seoul 137701, South Korea ckmin@catholic.ac.kr;
Clinical Impact of Lesion Complexity on 2-Year Outcomes After Zotarolimus-Eluting Stents Implantation Park, Jung-Ho Park, JH 1 Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Cardiol, Daegu, South Korea shur@dsmc.or.kr;
페이지 이동: